GLP1R and obstructive sleep apnea syndrome: This MR analysis identified an inverse association between GLP1R gene expression and the risk of OSA, suggesting that pharmacologic activation of the GLP‐1R—as achieved by GLP‐1R agonist use—may reduce OSA risk.